258 related articles for article (PubMed ID: 18279508)
1. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
[TBL] [Abstract][Full Text] [Related]
2. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
Kobayashi T; Tanaka K; Inoue K; Kakizuka A
J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
[TBL] [Abstract][Full Text] [Related]
3. Retrodifferentiation and rejuvenation of senescent monocytic cells requires PARP-1.
Selle A; Ullrich O; Harnacke K; Hass R
Exp Gerontol; 2007 Jun; 42(6):554-62. PubMed ID: 17314023
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of c-myc, max and mxi1 in human myeloid leukemia cells during retrodifferentiation and cell death.
Meinhardt G; Hass R
Leuk Res; 1995 Oct; 19(10):699-705. PubMed ID: 7500645
[TBL] [Abstract][Full Text] [Related]
5. Retrodifferentiation--an alternative biological pathway in human leukemia cells.
Hass R
Eur J Cell Biol; 1992 Jun; 58(1):1-11. PubMed ID: 1644056
[TBL] [Abstract][Full Text] [Related]
6. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
He J; Zhu Q; Wani G; Sharma N; Wani AA
J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
[TBL] [Abstract][Full Text] [Related]
7. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
He J; Zhu Q; Wani G; Wani AA
Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes.
Hass R; Gunji H; Datta R; Kharbanda S; Hartmann A; Weichselbaum R; Kufe D
Cancer Res; 1992 Mar; 52(6):1445-50. PubMed ID: 1531783
[TBL] [Abstract][Full Text] [Related]
9. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
10. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
[TBL] [Abstract][Full Text] [Related]
11. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
12. Disruption of p97/VCP induces autophagosome accumulation, cell cycle arrest and apoptosis in human choriocarcinoma cells.
Desdicioglu R; Sahin C; Yavuz F; Cayli S
Mol Biol Rep; 2021 Mar; 48(3):2163-2171. PubMed ID: 33620660
[TBL] [Abstract][Full Text] [Related]
13. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
[TBL] [Abstract][Full Text] [Related]
14. p37 regulates VCP/p97 shuttling and functions in the nucleus and cytosol.
Wrobel L; Hoffmann JL; Li X; Rubinsztein DC
Sci Adv; 2024 May; 10(18):eadl6082. PubMed ID: 38701207
[TBL] [Abstract][Full Text] [Related]
15. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation.
Ballar P; Shen Y; Yang H; Fang S
J Biol Chem; 2006 Nov; 281(46):35359-68. PubMed ID: 16987818
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
17. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
18. COP9 signalosome interacts ATP-dependently with p97/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97/VCP.
Cayli S; Klug J; Chapiro J; Fröhlich S; Krasteva G; Orel L; Meinhardt A
J Biol Chem; 2009 Dec; 284(50):34944-53. PubMed ID: 19826004
[TBL] [Abstract][Full Text] [Related]
19. The immunoexpression of valosin-containing protein and small VCP-interacting protein in rat ovaries.
Kartal B; Alimoğulları E; Çaylı S
Anat Histol Embryol; 2023 Jul; 52(4):546-551. PubMed ID: 36843060
[TBL] [Abstract][Full Text] [Related]
20. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]